SEC Filing Summary: Fidelity National Financial, Inc. (13F-HR)
Business Context and Reporting Period
This filing is a Form 13F-HR submitted by Fidelity National Financial, Inc., an institutional investment manager, for the quarter ended September 30, 2018. The report was signed by Michael L. Gravelle, EVP, General Counsel and Corporate Secretary, on November 1, 2018. This document discloses the equity securities held by the manager at the end of the reporting period.
Key Financial Metrics
As a Form 13F-HR, this filing reports portfolio holdings rather than the operating financial performance of Fidelity National Financial, Inc. itself. Key metrics from the filing include:
- Total Value of Reported Holdings: $682,483,000 (reported in thousands).
- Number of Holdings Reported: 24 entries.
- Other Included Managers: 0.
Note: Revenue, profit, cash flow, margins, debt, and liquidity figures for Fidelity National Financial, Inc. are not provided in this filing type.
Material Changes
The filing text does not provide a comparative table or narrative detailing material changes in holdings versus the prior comparable period (June 30, 2018). It only lists the aggregate value and count of holdings as of September 30, 2018.
Guidance, Outlook, and Risks
This filing contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. It is a statutory disclosure of investment positions required by the Securities and Exchange Commission.
Important Facts for Investor Verification
- Verify the specific list of 24 equity securities held by Fidelity National Financial, Inc. in the full schedule of the filing to understand their investment strategy.
- Confirm that the total reported value of $682.5 million represents the aggregate market value of the reported holdings, not the company's total assets or market capitalization.
- Note that this filing does not reflect the operational financial health of Fidelity National Financial, Inc.; refer to their 10-Q or 10-K filings for revenue and earnings data.